LYTIR

Company · IBRX

ImmunityBio, Inc.

Nasdaq's symbol directory lists IBRX on Nasdaq as “ImmunityBio, Inc. - Common Stock”.

In the 12 months to Nov 8, 2026: insiders sold on 7 occasions ($4.9M); 2 planned-sale notices; 1 filing by holders of 5% or more; 2 congressional trade disclosures; 1 company report (Form 8-K, since May 26, 2026).

All insider filings at the SEC

Insider purchases and sales, by month (last 12 months)Insider purchases: $0 in total; Insider sales: $4.9M in total.Jun: Insider sales $1.1MJul: Insider sales $2.7MOct: Insider sales $1.1MDecJanFebMarAprMayJunJulAugSepOctNov
Insider purchases above the line: $0Insider sales below: $4.9M
Dollar value of open-market purchases and sales reported on SEC Form 4, by the month traded. Sales include pre-arranged 10b5-1 plan sales.

Insider trades · SEC Form 4

Those inside the hall

Open-market purchases and sales only. Legs one person filed for one day are combined.

Who traded

  1. Selecky Christobel sold on 3 days all under a 10b5-1 plan latest Jul 1, 2026 sold $2.3M
  2. Cohen Cheryl sold on 2 days all under a 10b5-1 plan latest Oct 2, 2026 sold $2.1M
  3. Simon Barry J. sold on 2 days all under a 10b5-1 plan latest Oct 5, 2026 sold $466K
Every trade (7)
  1. SELLSimon Barry J. sold Oct 5, 2026 25,000 shares 10b5-1 plan (scheduled) filing $269K
  2. SELLCohen Cheryl sold Oct 2, 2026 81,056 shares 10b5-1 plan (scheduled) filing $851K
  3. SELLCohen Cheryl sold Jul 2, 2026 131,210 shares 10b5-1 plan (scheduled) filing $1.2M
  4. SELLSelecky Christobel sold Jul 1, 2026 159,478 shares 10b5-1 plan (scheduled) filing $1.4M
  5. SELLSelecky Christobel sold Jun 30, 2026 1,000 shares 10b5-1 plan (scheduled) filing $9K
  6. SELLSelecky Christobel sold Jun 29, 2026 95,722 shares 10b5-1 plan (scheduled) filing $862K
  7. SELLSimon Barry J. sold Jun 24, 2026 25,000 shares 10b5-1 plan (scheduled) filing $197K

Planned sales · SEC Form 144

Notice given

A Form 144 is filed before an insider sells restricted stock. It states an intent; the sale, if it happens, appears later on a Form 4. Every recent notice

  1. Simon Barry J. filed Oct 5, 2026 Officer 560,000 shares planned sale date 10/05/2026 filing $7.7M
  2. CHERYL COHEN filed Oct 2, 2026 Director 81,056 shares planned sale date 10/02/2026 filing $752K

Large holders · SEC Schedules 13D and 13G

Five percent and over

Anyone who comes to hold more than 5% of a company's voting shares must tell the SEC. A Schedule 13D is filed by a holder who may seek to influence the company; a 13G by one who states it is a passive investor. An amendment updates an earlier filing, and a stake reported as 0% means the holder says it has sold all, or nearly all, of its shares. Every recent 13D and 13G

  1. Cambridge Equities, LP filed Aug 6, 2026 Schedule 13D/A may seek influence 261,705,814 shares filing 24.7%

Congress · STOCK Act

The Althing

Periodic transaction reports. Amounts are the ranges members report; the trade date is when it happened, the report can come up to 45 days later.

  1. Lisa McClain (R-MI09): Purchase Sep 30, 2026 reported Oct 12, 2026 one of 9 trades the member reported that day House Stocks (including ADRs) owner: spouse $1,001 - $15,000
  2. Lisa McClain (R-MI09): Purchase Sep 28, 2026 reported Oct 12, 2026 one of 9 trades the member reported that day House Stocks (including ADRs) owner: spouse $1,001 - $15,000

Company reports · SEC Form 8-K

In its own words

Current reports the company filed with the SEC; most items are due within four business days of the event. Each line lists the report's items by the SEC's own titles; the filing says what happened. Reports collected since May 26, 2026; every 8-K at the SEC.

  1. Regulation FD disclosure filing Oct 14, 2026

Sources: SEC EDGAR (Forms 4, 144 and 8-K) and STOCK Act periodic transaction reports. Filings can be late, amended or wrong at the source; see methodology.